Close
Nordic 9Nordic 9

En Carta Diagnostics (private company)

France encarta.bio
See something wrong or missing? Let us know
Offices:Paris
Industry:Health servicesManufacturingPharma
Business model:B2B

En Carta Diagnostics is a health startup in France developing rapid Point-of-Care (POC) molecular diagnostics kits

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 1.61M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to En Carta Diagnostics

Name Criteria
France Pharmedigroup
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Pila Pharma
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Germany CEVEC Pharmaceuticals
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Grow Group
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Germany apriwell
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Brenus Pharma
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Vaxxel
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Oxford Drug Design
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Italy Ipsa
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Gate2Brain
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top